RNA Based Therapeutic Market Projected to Reach Valuation of USD 25.12 Billion at 17.6% CAGR from 2024-2030

According to the report, the global RNA based therapeutics industry was estimated at $4.93 billion in 2021, and is anticipated to hit $25.12 billion by 2030, registering a CAGR of 17.6% from 2021 to 2030.

The RNA based therapeutics has been explored as a promising treatment option for the diseases which are difficult to treat. Development of this therapeutics is based on promising technologies such as RNA interference technology (RNAi), antisense technology. Moreover, Cancer diagnosis and treatment is currently undergoing a shift with the incorporation of RNAi techniques in personalized medicine and molecular diagnostics, also for the diagnostic purposes, small interfering RNAs (siRNA) or microRNAs (miRNA) can be utilized.

Request Sample of the Report:

https://www.alliedmarketresearch.com/request-sample/546

Key Takeaways:

• The RNA interference (RNAi) segment, on the other hand, is expected to register the fastest CAGR of 18.8% throughout the forecast period.
• the genetic disorder segment is also projected to manifest the fastest CAGR of 18.2% from 2021 to 2030.
• The Asia-Pacific region is also expected to cite the fastest CAGR of 18.9% throughout the forecast period.

• Research Institutes continue to maintain lead in the forecast year

  Rise in initiatives from government for large-scale sequencing projects drives the growth of the global RNA based therapeutics market. On the other hand, hurdles in drug delivery, high cost of research, and threats of failure restrain the growth to some extent. However, early commercialization of pipeline therapeutics is expected to create lucrative opportunities in the industry.

  Factors affecting the growth of the RNA Based Therapeutic Market:

Technological Advancements:

• mRNA Technology: Innovations in messenger RNA (mRNA) technology have significantly boosted the potential of RNA-based therapeutics. The success of mRNA vaccines for COVID-19 (e.g., Pfizer-BioNTech and Moderna) has validated the technology and spurred further research and development.
• Delivery Systems: Advances in lipid nanoparticles and other delivery systems have improved the stability and efficiency of RNA-based drugs, making them more viable for therapeutic use.

Increasing Investment and Funding:

• Venture Capital: Growing interest from venture capitalists and private equity firms is fueling startups and established biotech companies focused on RNA therapeutics.
• Government and Public Funding: Increased funding from governments and public health organizations, particularly in the wake of the COVID-19 pandemic, supports research and development.

Expanding Applications:

• Diverse Therapeutic Areas: RNA-based therapeutics are being explored for a wide range of applications, including cancer, infectious diseases, genetic disorders, and cardiovascular diseases.
• Personalized Medicine: The potential for RNA therapeutics to be tailored to individual genetic profiles enhances their appeal in personalized medicine.

Strategic Collaborations and Partnerships:

• Pharmaceutical Collaborations: Partnerships between biotech companies and large pharmaceutical firms enhance research capabilities, access to resources, and market reach.
• Academic and Research Institutions: Collaborations with universities and research institutions foster innovation and provide access to cutting-edge research.

Connect to our Analyst:

https://www.alliedmarketresearch.com/connect-to-analyst/546

RNA Based Therapeutic Market Segments:

By Type:

• RNA Interference (RNAi)
• RNA Antisense

APPLICATION

• Genetic Disorders
• Auto immune disorders

By END USER

• Research Institutes
• Hospitals & Clinics

By Region

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific (Australia, Japan, China, India, South Korea, Rest of Asia-Pacific)
• LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Regional Analysis:

The market across North America dominated in 2020, garnering more than two-fifths the global RNA based therapeutics market. High expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region propel the market growth. Simultaneously, the Asia-Pacific region is also expected to cite the fastest CAGR of 18.9% throughout the forecast period. This is attributed to improvements in R&D facilities, available disposable income, and rapidly developing economic conditions.

Key players in the industry:

• Silence Therapeutics plc.
• Arbutus Biopharma Corporation
• Ionis Pharmaceuticals
• Sarepta Therapeutics
• Alnylam Pharmaceuticals, Inc.
• Benitec Biopharma Inc.
• Genzyme (Sanofi), Arrowhead Pharmaceuticals
• Biogen, Inc.
• Gradalis, Inc.

For Purchase Inquiry- 

https://www.alliedmarketresearch.com/purchase-enquiry/546

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Request Customization: 

https://www.alliedmarketresearch.com/request-for-customization/546

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Data
David Correa

1209 Orange Street, Corporation Trust Center, Wilmington, New Castle, Delaware 19801 USA.

Toll Free: +1-800-792-5285| Int’l: +1-503-894-6022

UK: +44-845-528-1300| Hong Kong: +852-301-84916

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

Trending Reports in Healthcare Industry (Book Now with Discount):

Medical Device Packaging Market Research Report 2024 To 2032 

Acupuncture Needles Market Research Report 2024 To 2032 

Veterinary Medicine Market Research Report 2024 To 2032 

Implantable Insulin Pump Market Research Report 2024 To 2032